MACOM Technology vs Pfizer Inc — how do they compare? MACOM Technology trades at $284.04 (market cap $20.99B), while Pfizer Inc trades at $27.89 (market cap $158.39B). The key difference: Pfizer Inc is far larger — about 7.5× MACOM Technology's market cap, and Pfizer Inc pays a 6.19% dividend while MACOM Technology pays none. Which is the better fit depends on your goals.
| MTSI | PFE | |
|---|---|---|
Market Cap | $20.99B | $158.39B |
Sector | Technology | Health |
52-Week High | $409.68 | $29.02 |
52-Week Low | $122.18 | $23.60 |
Enterprise Value | $20.70B | $209.89B |
Volume | — | 29,869,932 |
Dividend Yield | — | 6.19% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
Trailing returns across standard periods
Latest headlines on both assets
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →